PHRMA INC.
Represents leading research-based pharmaceutical and biotechnology companies in the US
Based in DC
AI Overview
With $2.1M in lobbying spend across 29 quarterly filings, PHRMA INC is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $300K |
| 2019 | $275K |
| 2020 | $300K |
| 2021 | $300K |
| 2022 | $300K |
| 2023 | $300K |
| 2024 | $300K |
| 2025 | $25K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that PHRMA INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Trade
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.